How many institutions own OCX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own OCX shares is 34, representing 56.3% of the company's common stock.

Who are the major shareholders selling OncoCyte Corporation stock?

DEFENDER CAPITAL, LLC., in the last quarter, reduced its stake in OCX by -5.74% restricting it's holding to 44.38 thousand shares of worth nearly $126.92K. DEFENDER CAPITAL, LLC. also lessened -22% of the OCX shares from its portfolio, reducing its holding to 55.89 thousand shares of worth $163.74K. DEFENDER CAPITAL, LLC. also shunned OCX shares holding by -37.43% last quarter which brought its holding to 71.65 thousand shares worth $179.13K.

Investors who are buying OCX stock?

As per its latest 13F filing, AWM INVESTMENT COMPANY, INC. increased its stake in OCX by 4.87% in the last quarter. The institutional holder raised its holding to 754.29 thousand shares having worth more than $1.87M. N/A also added N/A more shares of OCX to its portfolio, raising its holding to - shares of worth -. N/A also increased its OCX shares holding by N/A which brought its holding to - shares worth -.

OCX's major insiders: who are they?

The insider with the most stakes in OCX is BROADWOOD CAPITAL INC , at the company. Additionally, OCX stock is highly held by 10 percent owner BIOTIME INC and Kamen Efrem among others.

Did an insider recently sell OCX stock?

Company executives, directors, and other insiders own 22.03% percent of OncoCyte Corporation's stock. Within the last six months, there have been 0 transaction(s) in which OCX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include PURA VIDA INVESTMENTS, LLC, KAMEN EFREM, and YU LI.

Which insider recently purchased OCX stock?

There have been 0 transaction(s) during the past 6-months in which OncoCyte Corporation insiders have bought stock, totalling 0 shares

How much of OCX does insiders own?

Around 0 OncoCyte Corporation shares are held by insiders, which represents about 22.03% of OCX stock.

Who is the insider with the largest stake?

OCX , BROADWOOD CAPITAL INC holds the largest portfolio of the company's shares. OCX shares owned by BROADWOOD total nearly 23.35 million.

Which institution holds the most shares in OCX?

DEFENDER CAPITAL, LLC. is the largest institutional owner in OCX which holds 44.38 thousand shares worth $126.92K or 0.17% of the total OCX shares outstanding followed by DEFENDER CAPITAL, LLC. with ownership of 55.89 thousand shares representing 0.73% of the OCX ownership. AWM INVESTMENT COMPANY, INC. is the third largest stakeholder with 754.29 thousand shares or 9.86% of the ownership worth more than $2.21M.

Is OncoCyte Corporation stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the OCX is concerned, it is a stock which is not optionable.

Is there a short position on OCX's shares?

Number of OCX shares short is 403.36K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding OCX shares are there?

As of today, 28.60M shares of OCX are outstanding.

Is there many float in OCX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, OCX has 10.38M shares in float.

OCX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for OCX is 8.11.

OncoCyte (OCX) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares1.41

Short Percent Of Float2.99

Shares Outstanding28.60M

Shares Float10.38M

Shares Short403.36K

Short Ratio8.11

2.99%

Short % of Float

1.41%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

22.03% Percentage of Shares held by All Insiders

56.3% Percentage of Shares held by All Institutions

72.21% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 56.3% of OCX shares are held by financial institutions. DEFENDER CAPITAL, LLC. is the top corporate investor, holding 44.38K shares valued at $126.92K. A 0.17% stake in OncoCyte Corporation is owned by the company. DEFENDER CAPITAL, LLC. owns 55.89K shares valued at $163.74K, which translates its holding of 0.73% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2025	DEFENDER CAPITAL, LLC.	0.17%	44.38K	126.92K	-2.7K	-5.74%
Mar 31, 2024	DEFENDER CAPITAL, LLC.	0.73%	55.89K	163.74K	-15.77K	-22.00%
Mar 31, 2024	AWM INVESTMENT COMPANY, INC.	9.86%	754.29K	2.21M	0	0
Dec 31, 2023	AWM INVESTMENT COMPANY, INC.	9.14%	754.29K	1.87M	35K	+4.87%
Dec 31, 2023	DEFENDER CAPITAL, LLC.	0.87%	71.65K	179.13K	-42.87K	-37.43%

Insiders

Among the OCX insiders holding of 22.03% of the stake in company, BROADWOOD CAPITAL INC, , holds the largest shares of 23.35M. BIOTIME INC, 10 percent owner, is the second largest OCX insider with ownership of 12.42M shares. KAMEN EFREM, , stands third with possession of 8.52M shares of that stake.

Insiders	Designation	Shares Held
BROADWOOD CAPITAL INC		23.35M
BIOTIME INC	10 percent owner	12.42M
KAMEN EFREM		8.52M
PURA VIDA INVESTMENTS, LLC	10 percent owner	8.09M
BROADWOOD PARTNERS, L.P.	10 percent owner	6.9M
LINEAGE CELL THERAPEUTICS, INC.		6.04M
SMITH PATRICK W	10 percent owner	2.87M
KINGSLEY ALFRED D	director	469.11K
ANDREWS RONALD ASBURY	President & CEO	333.21K
JAMES ANDREA S.	Chief Financial Officer	151.23K
REDMOND CAVAN M.		110.86K
LEVINE MITCHELL S	Chief Financial Officer	87.08K
ARNO ANDREW	director	81.55K
GUTFREUND JOHN PETER	director	75K
LAST ANDREW J.		70.17K
CARTER JENNIFER L.		30.5K
GRIFFITH MELINDA		30K
ROSS DOUGLAS T.	Chief Scientific Officer	20.32K
YU LI	VP Cntrllr/Prncpl Acctng Offcr	16.87K
PAULSEN GISELA	Chief Operating Officer	16.5K
KALAJIAN TONY T	Sr.VP/Chief Accounting Officer	15K
PARKER ALBERT P	Chief Operating Officer	5K
RIGGS JOSH	CEO and President	3.51K
ANNETT WILLIAM	President and CEO	3.5K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Feb 07, 2025	SMITH PATRICK W	PURCHASE	2.05	1.08M	2.21M	2.87M
Feb 07, 2025	JAMES ANDREA S.	PURCHASE	2.05	97.56K	200K	151.23K
Feb 06, 2025	BROADWOOD PARTNERS, L.P.	PURCHASE	2.05	660.21K	1.35M	6.9M
Feb 04, 2025	SMITH PATRICK W	PURCHASE	2.02	25	50.5	1.8M
Jan 31, 2025	SMITH PATRICK W	PURCHASE	2.01	890	1.79K	1.8M
Jan 30, 2025	SMITH PATRICK W	PURCHASE	2.01	318	639.18	1.79M
Jan 29, 2025	SMITH PATRICK W	PURCHASE	2.01	3.88K	7.8K	1.79M
Jan 14, 2025	SMITH PATRICK W	PURCHASE	2.08	100	208	1.78M
Jan 13, 2025	SMITH PATRICK W	PURCHASE	2.08	5.67K	11.79K	1.78M
Dec 26, 2024	ARNO ANDREW	PURCHASE	2.11	12.5K	26.35K	81.55K
Dec 26, 2024	SMITH PATRICK W	PURCHASE	2.13	90.22K	192.17K	1.77M
Dec 05, 2024	JAMES ANDREA S.	PURCHASE	2.29	20K	45.8K	53.67K
Oct 02, 2024	JAMES ANDREA S.	PURCHASE	2.97	33.67K	100K	33.67K
Oct 02, 2024	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	6.24M
Apr 11, 2024	ARNO ANDREW	PURCHASE	2.95	33.9K	100K	69.05K
Apr 11, 2024	RIGGS JOSH	PURCHASE	2.95	3.39K	10K	3.51K
Apr 11, 2024	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	4.93M
Jun 14, 2023	KINGSLEY ALFRED D	PURCHASE	0.21	30K	6.45K	469.11K
Apr 05, 2023	PURA VIDA INVESTMENTS, LLC	PURCHASE	0.30	663K	200.03K	8.09M
Apr 03, 2023	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	50.18M
Dec 23, 2022	ARNO ANDREW	PURCHASE	0.35	250K	87.88K	532.05K
Dec 23, 2022	GUTFREUND JOHN PETER	PURCHASE	0.33	75K	24.73K	75K
Dec 22, 2022	KINGSLEY ALFRED D	PURCHASE	0.28	25K	7.13K	439.11K
Aug 17, 2022	LAST ANDREW J.	PURCHASE	0.87	20K	17.4K	70.17K
Aug 17, 2022	ARNO ANDREW	PURCHASE	0.90	7.5K	6.75K	15K
Aug 16, 2022	ANDREWS RONALD ASBURY	PURCHASE	0.96	40K	38.4K	333.21K
Aug 15, 2022	CARTER JENNIFER L.	PURCHASE	0.95	10.5K	9.98K	30.5K
Aug 15, 2022	KINGSLEY ALFRED D	PURCHASE	0.97	5K	4.85K	409.11K
Aug 15, 2022	GUTFREUND JOHN PETER	PURCHASE	0.93	25K	23.25K	25K
Aug 15, 2022	ARNO ANDREW	PURCHASE	0.93	34.48K	32.06K	166.53K
Aug 15, 2022	GRIFFITH MELINDA	PURCHASE	1.00	10K	10K	30K
Jun 24, 2022	PURA VIDA INVESTMENTS, LLC	SALE	1.03	35.44K	36.39K	7.43M
Jun 24, 2022	KAMEN EFREM	SALE	1.05	12.52K	13.16K	8.52M
May 18, 2022	YU LI	SALE	1.14	8.13K	9.27K	16.87K
Apr 14, 2022	PURA VIDA INVESTMENTS, LLC	PURCHASE	1.53	383.98K	587.48K	383.98K
Apr 14, 2022	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	23.35M
Apr 14, 2022	KAMEN EFREM	PURCHASE	1.33	767.95K	1.02M	767.95K
Apr 13, 2022	BROADWOOD CAPITAL INC	PURCHASE	1.33	6M	8M	23.35M
Mar 25, 2022	ROSS DOUGLAS T.	PURCHASE	1.40	15K	21K	20.32K
Mar 16, 2022	ANDREWS RONALD ASBURY	PURCHASE	1.28	50K	64.15K	293.21K
Mar 16, 2022	REDMOND CAVAN M.	PURCHASE	1.19	40K	47.56K	110.86K
Mar 15, 2022	ANDREWS RONALD ASBURY	PURCHASE	1.28	50K	64.15K	293.21K
Mar 15, 2022	PAULSEN GISELA	PURCHASE	1.20	16.5K	19.77K	16.5K
Mar 15, 2022	LEVINE MITCHELL S	PURCHASE	1.17	25K	29.15K	87.08K
Mar 19, 2021	ANDREWS RONALD ASBURY	PURCHASE	4.79	11K	52.7K	113.7K
Feb 05, 2021	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	16.78M
Jan 20, 2021	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	16.18M
Dec 23, 2020	KINGSLEY ALFRED D	SALE	2.55	900	2.3K	318.84K
Dec 22, 2020	KINGSLEY ALFRED D	SALE	2.54	7.65K	19.44K	318.5K
Dec 21, 2020	KINGSLEY ALFRED D	SALE	2.54	5.15K	13.08K	315.64K
Sep 12, 2020	LEVINE MITCHELL S	PURCHASE	2.01	10K	20.06K	13.5K
Aug 03, 2020	PARKER ALBERT P	PURCHASE	1.33	5K	6.65K	5K
Aug 03, 2020	LEVINE MITCHELL S	PURCHASE	1.32	10K	13.2K	36.58K
Aug 03, 2020	ANDREWS RONALD ASBURY	PURCHASE	1.35	40K	53.88K	102.7K
Aug 03, 2020	KALAJIAN TONY T	PURCHASE	1.31	5K	6.53K	15K
Apr 24, 2020	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	14.72M
Mar 31, 2020	ANDREWS RONALD ASBURY	PURCHASE	2372.00	18K	42.7M	62.7K
Mar 30, 2020	ANDREWS RONALD ASBURY	PURCHASE	2.26	27.22K	61.45K	44.7K
Jan 02, 2020	LINEAGE CELL THERAPEUTICS, INC.	SALE	2.16	2.38M	5.14M	6.04M
Jan 02, 2020	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	13.04M
Nov 13, 2019	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	12.27M
Sep 17, 2019	ARNO ANDREW	PURCHASE	2.16	50K	108.13K	102.45K
Sep 13, 2019	KALAJIAN TONY T	PURCHASE	1.98	10K	19.8K	10K
Sep 12, 2019	LEVINE MITCHELL S	PURCHASE	2.01	10K	20.06K	10K
Sep 11, 2019	LINEAGE CELL THERAPEUTICS, INC.	SALE	1.66	4M	6.64M	8.42M
Sep 11, 2019	BROADWOOD PARTNERS, L.P.	PURCHASE	0.00	0	-	11.1M
Jul 05, 2019	BIOTIME INC	SALE	2.00	2.25M	4.5M	12.42M
Jul 02, 2019	BROADWOOD PARTNERS, L.P.	PURCHASE	2.00	0	-	9.1M
Feb 08, 2019	BROADWOOD PARTNERS, L.P.	PURCHASE	3.75	0	-	8.1M
Jul 26, 2018	ANNETT WILLIAM	PURCHASE	2.86	3.5K	10.01K	3.5K
Jul 26, 2018	ANDREWS RONALD ASBURY	PURCHASE	2.86	17.48K	50K	17.48K

OCX Stock Ownership Breakdown

OncoCyte

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions